×

ACM Global Central Laboratory Announces Isabel Struik as Head of Business Development, Europe

Seasoned Executive Brings Extensive Logistics Knowledge and Best Practices for Expanding Central Lab Activities in Europe


York, England, May 3, 2012 – ACM Global Central Lab, the central laboratory that continually defines the customer-service standard with its flexible approach, is pleased to announce that Isabel Struik has joined the executive management team as head of business development in Europe and will be responsible for business development efforts throughout the region. Struik brings vast experience in the clinical research arena to ACM Global having worked in the clinical trials industry for more than thirteen years and in all major therapeutic areas.

Prior to joining ACM Global, Struik was director of business development at CROMSOURCE, an international provider of clinical development services, where she was head of the business development unit and a member of the organization’s steering committee. Prior to that, she was associate director, business development for PharmaNet, where she was responsible for establishing a generics and biosimilars product portfolio for late stage studies. Struik also spent several years at Kendle International, where she served in roles of increasing strategic responsibility, including business development and support manager.

“Isabel has extensive business development experience in the clinical trials industry and a thorough understanding of the logistics and challenges involved when it comes to central lab activities in clinical research,” said Angela J. Panzarella, president of ACM Global Central Lab. “We are thrilled to welcome her to our team.”

ACM Global will be on hand to discuss the latest trends in clinical research lab testing at Outsourcing in Clinical Trials, May 8-9, in Zurich, Switzerland.

About ACM Global Central Lab
ACM Global Central Lab offers a flexible approach and a focus on precision to keep clinical research studies on schedule. ACM’s services extend to more than 60 countries with all tests conducted and managed from central lab facilities with seamless data management providing a single database. The organization performs 13 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ensures clients receive consistent, analyzable test results with faster and cleaner reporting.

For more information, visit www.acmgloballab.com and our Central Labs in Focus blog at www.acmgloballab.com/blog.
 

email us at: info@acmgloballab.com
© ACM Global Laboratories 2017.
All rights reserved

HIPAA Privacy Statement